The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2008

Filed:

Aug. 27, 2003
Applicants:

Michael Buschle, Perchtoldsdorf, AT;

Andre Habel, Vienna, AT;

Christoph Klade, Wr. Neustadt, AT;

Frank Mattner, Vienna, AT;

Alexander Otava, Vienna, AT;

Oresta Vytvytska, Vienna, AT;

Wolfgang Zauner, Vienna, AT;

Sandra Zinke, Vienna, AT;

Helen Kirlappos, Vienna, AT;

Inventors:

Michael Buschle, Perchtoldsdorf, AT;

Andre Habel, Vienna, AT;

Christoph Klade, Wr. Neustadt, AT;

Frank Mattner, Vienna, AT;

Alexander Otava, Vienna, AT;

Oresta Vytvytska, Vienna, AT;

Wolfgang Zauner, Vienna, AT;

Sandra Zinke, Vienna, AT;

Helen Kirlappos, Vienna, AT;

Assignee:

Intercell AG, Vienna, AT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 51/00 (2006.01); A61K 39/12 (2006.01); A61K 39/29 (2006.01); C12Q 1/70 (2006.01);
U.S. Cl.
CPC ...
Abstract

Described is a method for isolating Hepatitis C Virus peptides (HPs) which have a binding capacity to a MHC/HLA molecule or a complex comprising said HCV-peptide and said MHC/HLA molecule characterized by the following steps: —providing a pool of HCV-peptide, said pool containing HCV-peptides which bind to said MHC/HLA molecule and HCV-peptides which do not bind to said MHC/HLA molecule, —contacting said MHC/HLA molecule with said pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to said MHC/HLA molecule binds to said MHC/HLA molecule and a complex comprising said HCV-peptide and said MHC/HLA molecule is formed, —detecting and optionally separating said complex from the HCV-peptide which do not bind to said MHC/HLA molecule and optionally isolating and characterizing the HCV-peptide from said complex.


Find Patent Forward Citations

Loading…